SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: ajs who wrote (867)3/6/1999 6:52:00 PM
From: capitalistbeatnik  Read Replies (1) | Respond to of 1754
 
I'd sooner let Uncle Ernie tell me when to buy and sell than Chip. God, if you're going to short a stock there are plenty out there that have no earnings and plenty of competition.



To: ajs who wrote (867)3/7/1999 12:07:00 PM
From: investor  Read Replies (1) | Respond to of 1754
 
Visx might have one more quarterbut remember:1.most of their income comes from licensing.2.NiCad doesn't charge any fees.3.Visx already lost 2 patent cases in Europe.4.other mfgs. are also in the market.5.try talking to some doctors Patience is the key here.Chip will be right.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News